Clinical Trial Update: A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating nintedanib/placebo in combination with induction chemotherapy for relapsed or refractory acute myeloid leukemia; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Yale University | Conditions: Relapsed/Refractory Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-04-08